Dr. Minglin Ma is a co-author on a newly published review of diabetes cell therapies

Minglin Ma is co-author of “Harnessing Cellular Therapeutics for Type 1 Diabetes Mellitus: Progress, Challenges, and the Road Ahead” in the journal Nature Reviews Endocrinology.

September 3, 2024

https://pubmed.ncbi.nlm.nih.gov/39227741

This review article describes current, developing and future cell replacement therapy options, touching on animal models and the regulatory environment.